These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15316408)

  • 1. Haemochromatosis: find them or forget about them?
    Adams PC
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):857-8. PubMed ID: 15316408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening.
    Gleeson F; Ryan E; Barrett S; Crowe J
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):859-63. PubMed ID: 15316409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: the modern diagnosis and management of haemochromatosis.
    Adams PC
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemochromatosis and the liver.
    Niederau C; Erhardt A; Häussinger D; Strohmeyer G
    J Hepatol; 1999; 30 Suppl 1():6-11. PubMed ID: 10370895
    [No Abstract]   [Full Text] [Related]  

  • 6. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemochromatosis in patients with beta-thalassaemia trait.
    Piperno A; Mariani R; Arosio C; Vergani A; Bosio S; Fargion S; Sampietro M; Girelli D; Fraquelli M; Conte D; Fiorelli G; Camaschella C
    Br J Haematol; 2000 Dec; 111(3):908-14. PubMed ID: 11122155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemochromatosis and HFE gene.
    Moirand R; Deugnier Y; Brissot P
    Acta Gastroenterol Belg; 1999; 62(4):403-9. PubMed ID: 10692770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: haemochromatosis.
    Whittington CA; Kowdley KV
    Aliment Pharmacol Ther; 2002 Dec; 16(12):1963-75. PubMed ID: 12452931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic individuals at genetic risk of haemochromatosis take appropriate steps to prevent disease related to iron overload.
    Allen KJ; Nisselle AE; Collins VR; Williamson R; Delatycki MB
    Liver Int; 2008 Mar; 28(3):363-9. PubMed ID: 18290779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A coding polymorphism in the BMP2 gene is associated with iron overload in non-HFE haemochromatosis patients.
    Lamoril J; Theou-Anton N; Tchernitchko D
    Blood Cells Mol Dis; 2015 Dec; 55(4):318-9. PubMed ID: 26460254
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.
    McCune CA; Ravine D; Carter K; Jackson HA; Hutton D; Hedderich J; Krawczak M; Worwood M
    Gut; 2006 Apr; 55(4):554-62. PubMed ID: 16174659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?
    Adams PC
    Mol Genet Metab; 2000; 71(1-2):81-6. PubMed ID: 11001800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of haemochromatosis gene mutations in the general population: implications for screening.
    Burt MJ; George PM; Upton JD; Collett JA; Frampton CM; Chapman TM; Walmsley TA; Chapman BA
    Gut; 1998 Dec; 43(6):830-6. PubMed ID: 9824612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: targeted screening for hereditary haemochromatosis in high-risk groups.
    DuBois S; Kowdley KV
    Aliment Pharmacol Ther; 2004 Jul; 20(1):1-14. PubMed ID: 15225165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
    Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
    J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.